VELOXIS PHARMACEUTICALS A/S: Financial statements 2015
CVR: 26527767
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
VELOXIS PHARMACEUTICALS A/S (CVR 26527767) has filed annual accounts for 2015. In 2015, the company reported revenue of DKK 14,150,000 and a net result of DKK -176,106,000 compared with DKK -36,319,000 the year before. That is a decrease of 88.5% compared with the year before. The profit margin was -1,244.6%. Equity in the 2015 report amounted to DKK 89,659,000. The solvency ratio was 60.2%.
- Revenue
- DKK 14,150,000
- Gross Profit
- DKK -989,000
- Profit/Loss
- DKK -176,106,000
- Equity
- DKK 89,659,000
- Total Assets
- DKK 148,953,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | 14.2M | -989K | -176.1M | 89.7M | - |
| 2014 | 123.4M | 120.1M | -36.3M | 253.2M | - |
Official annual report
How creditworthy is VELOXIS PHARMACEUTICALS A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of December 10, 2015, Craig Alexander Collard is registered as adm. dir. of VELOXIS PHARMACEUTICALS A/S.
As of December 10, 2015, William James Polvino has stepped down as adm. dir. of VELOXIS PHARMACEUTICALS A/S.
VELOXIS PHARMACEUTICALS A/S has published its interim report for the period January 1, 2015 to September 30, 2015.
VELOXIS PHARMACEUTICALS A/S has published its interim report for the period January 1, 2015 to June 30, 2015.
VELOXIS PHARMACEUTICALS A/S has published its interim report for the period January 1, 2015 to March 31, 2015.
VELOXIS PHARMACEUTICALS A/S has published its annual report for 2014. Revenue came to DKK 123,395,000, and the net result was DKK -36,319,000.
As of March 26, 2015, Mette Kirstine Agger has joined the board of directors of VELOXIS PHARMACEUTICALS A/S.
As of March 26, 2015, Michael Thomas Heffernan has joined the board of directors of VELOXIS PHARMACEUTICALS A/S.
As of March 26, 2015, Kim Bjørnstrup has left the board of directors of VELOXIS PHARMACEUTICALS A/S.
As of March 25, 2015, Mette Kirstine Agger has left the board of directors of VELOXIS PHARMACEUTICALS A/S.
About VELOXIS PHARMACEUTICALS A/S
VELOXIS PHARMACEUTICALS A/S is a Danish company of the type Aktieselskab based in Nordhavn, founded in 2002. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named LIFECYCLE PHARMA A/S and PHAROTECH A/S. The management consists of Daisuke Matsuo. The board consists of Keigo Nakatsukasa (chair), Daisuke Matsuo and Kenro Yuzaki. The company is owned by Asahi Kasei Corporation. The company has 1 employee (2022). In 2026, the company reported a net result of DKK -1,553,000. Equity in the 2026 report amounted to DKK 611,587,000.